Dual complement inhibition by CRIg/FH shows renoprotective effect in ischemia reperfusion injury Feb. 18, 2019 No Comments
New phase III study of empagliflozin assesses cardio-renal outcomes in chronic kidney disease Feb. 8, 2019 No Comments
Nash Pharmaceuticals reports preclinical activity and new compounds for kidney disease Jan. 15, 2019 No Comments
Regulus reports preliminary interim data from mouse chronic toxicity study of RGLS-4326 Jan. 7, 2019 No Comments
RSS